Whole-Blood RNA Profiles Associated with Pulmonary Arterial Hypertension and Clinical Outcome
暂无分享,去创建一个
M. Dunning | M. Humbert | D. Trégouët | I. Prokopenko | L. Harbaum | P. Corris | S. Gräf | R. Trembath | Dennis Wang | N. Morrell | J. Wharton | M. Wilkins | D. Kiely | C. Rhodes | E. Swietlik | L. Howard | W. Nichols | S. Wort | A. Desai | L. Southgate | C. Church | M. Toshner | A. Lawrie | J. Elinoff | J. Iremonger | J. Coghlan | Pablo Otero-Núñez | J. Pepke‐Zaba | A. Thomson | S. Kariotis | N. Errington | J. Pepke-Zaba | A. Thompson
[1] Yuan Guo,et al. The Role of Regulatory T Cells in Pulmonary Arterial Hypertension , 2019, Journal of the American Heart Association.
[2] E. Mickler,et al. Systems Analysis of the Human Pulmonary Arterial Hypertension Lung Transcriptome. , 2019, American journal of respiratory cell and molecular biology.
[3] Lisa J. Martin,et al. Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis , 2018, bioRxiv.
[4] R. Danner,et al. Meta-analysis of Blood Genome-Wide Expression Profiling Studies in Pulmonary Arterial Hypertension. , 2019, American journal of physiology. Lung cellular and molecular physiology.
[5] A. Pegg,et al. Polyamine metabolism and cancer: treatments, challenges and opportunities , 2018, Nature Reviews Cancer.
[6] Yu Wang,et al. Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data , 2017, Genome Medicine.
[7] Henning Gall,et al. Identification of rare sequence variation underlying heritable pulmonary arterial hypertension , 2018, Nature Communications.
[8] M. Humbert,et al. Plasma proteome analysis in patients with pulmonary arterial hypertension: an observational cohort study , 2017, The Lancet. Respiratory medicine.
[9] H. Hedlin,et al. Randomised placebo-controlled safety and tolerability trial of FK506 (tacrolimus) for pulmonary arterial hypertension , 2017, European Respiratory Journal.
[10] Jodie L Babitt,et al. Smad1/5 is required for erythropoietin-mediated suppression of hepcidin in mice. , 2017, Blood.
[11] Cizhong Jiang,et al. Smad5 acts as an intracellular pH messenger and maintains bioenergetic homeostasis , 2017, Cell Research.
[12] Geet Duggal,et al. Salmon: fast and bias-aware quantification of transcript expression using dual-phase inference , 2017, Nature Methods.
[13] P. Corris,et al. Plasma Metabolomics Implicates Modified Transfer RNAs and Altered Bioenergetics in the Outcomes of Pulmonary Arterial Hypertension , 2017, Circulation.
[14] Roby Joehanes,et al. Integrated genome-wide analysis of expression quantitative trait loci aids interpretation of genomic association studies , 2017, Genome Biology.
[15] M. Humbert,et al. Regulatory T Cell Dysfunction in Idiopathic, Heritable and Connective Tissue-Associated Pulmonary Arterial Hypertension. , 2016, Chest.
[16] F. Saudek,et al. Unstable Expression of Commonly Used Reference Genes in Rat Pancreatic Islets Early after Isolation Affects Results of Gene Expression Studies , 2016, PloS one.
[17] Stephen Burgess,et al. Combining information on multiple instrumental variables in Mendelian randomization: comparison of allele score and summarized data methods , 2015, Statistics in medicine.
[18] D. Geerts,et al. ATP13A3 and caveolin-1 as potential biomarkers for difluoromethylornithine-based therapies in pancreatic cancers. , 2016, American journal of cancer research.
[19] Simon Gibbs,et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension , 2015, European Respiratory Journal.
[20] S. Gräf,et al. Selective enhancement of endothelial BMPR-II with BMP9 reverses pulmonary arterial hypertension , 2015, Nature Medicine.
[21] Ash A. Alizadeh,et al. Robust enumeration of cell subsets from tissue expression profiles , 2015, Nature Methods.
[22] S. Rich,et al. Peripheral Blood Signature of Vasodilator-Responsive Pulmonary Arterial Hypertension , 2015, Circulation.
[23] M. Humbert,et al. Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension. , 2014, Circulation research.
[24] W. Seeger,et al. Impact of S-Adenosylmethionine Decarboxylase 1 on Pulmonary Vascular Remodeling , 2014, Circulation.
[25] M. Humbert,et al. Upfront triple combination therapy in pulmonary arterial hypertension: a pilot study , 2014, European Respiratory Journal.
[26] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[27] T. Gudermann,et al. Classical transient receptor potential channel 1 in hypoxia-induced pulmonary hypertension. , 2013, American Journal of Respiratory and Critical Care Medicine.
[28] M. Peters,et al. Systematic identification of trans eQTLs as putative drivers of known disease associations , 2013, Nature Genetics.
[29] N. Morrell,et al. Correction of nonsense BMPR2 and SMAD9 mutations by ataluren in pulmonary arterial hypertension. , 2013, American journal of respiratory cell and molecular biology.
[30] J. Wharton,et al. Iron deficiency and raised hepcidin in idiopathic pulmonary arterial hypertension: clinical prevalence, outcomes, and mechanistic insights. , 2011, Journal of the American College of Cardiology.
[31] Xavier Robin,et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves , 2011, BMC Bioinformatics.
[32] Mark D. Robinson,et al. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..
[33] R. Speich,et al. Increased Regulatory and Decreased CD8+ Cytotoxic T Cells in the Blood of Patients with Idiopathic Pulmonary Arterial Hypertension , 2007, Respiration.